Stocks in news May 8th: RIL, RBL Bank, HUL, Gillette, SKF, Just Dial

Stocks in news May 8th: RIL, RBL Bank, HUL, Gillette, SKF, Just Dial Stocks in news May 8th: The early trade of both Sensex and Nifty reported a bullish trend in the stock market on Friday. The Sensex is trading above 31,500 level, and Nifty is trading above the 9,300... The post Stocks in news May 8th: RIL, RBL Bank, HUL, Gillette, SKF, Just Dial appeared first on stockinvestor.in.

Stocks in news May 8th: RIL, RBL Bank, HUL, Gillette, SKF, Just Dial

Stocks in news May 8th: RIL, RBL Bank, HUL, Gillette, SKF, Just Dial

Stocks in news May 8th: The early trade of both Sensex and Nifty reported a bullish trend in the stock market on Friday. The Sensex is trading above 31,500 level, and Nifty is trading above the 9,300 level in the stock market. The Sensex gained 443.59 points with a 1.41% increase and reached a 31,889.27 level. While Nifty gained 130.35 points with a 1.42% increase and reached 9,330.70 level.

On the other side, the number of coronavirus cases in India reached 56,342 as of Friday, May 8th, and deaths reached 1,886.

Besides, there are some stocks in the news on May 8th stock market are:

RIL Industries Limited: The company shares bought by Vista Equity Partners by 2.32% stakes in the Jio Platform for Rs 11,367 crores. 

However, RIL Industries Ltd on Friday reported a bullish trend in the stock market. The company gained 53.80 points with a 3.57% increase and reached 1,560.75 INR. While in BSE, the company gained 53.05 points with a 3.52% increase and reached 1,560.30 INR. 

RBL Bank Limited: The bank on Thursday reported its Q4 results. The bank’s profit decreased to Rs 114.36 crores as against Rs 247.18 crores. The companies revenue increased by Rs 1,021 crores as against Rs 738.72 crores YoY.

However, RBL Bank  Ltd on Friday reported a bullish trend in the stock market. The bank gained 1.05 points with a 0.81% increase and reached 129.90 INR. While in BSE, the bank gained 1.00 points with a 0.78% increase and reached 129.90 INR. 

Gillette India Limited: The company on Thursday reported its Q4 results. The company’s profit decreased to Rs 52.38 crores as against Rs 87.76 crores. The companies revenue decreased to Rs 406.57 crores as against Rs 465.51 crores YoY.

However, Gillette India Ltd on Friday reported a bearish trend in the stock market. The company lost 51.90 points with a 1.04% decrease and reached 4,933.95 INR. While in BSE, the company lost 51.00 points with a 1.02% decrease and reached 4,939.90 INR.

Cyient Limited: The shares of the company bought by Amansa Holdings Limited by almost 21,11,780 equity shares for Rs 205 per share. On the other side, the company reported its Q4 results profit fell to Rs 45.2 crores against Rs 176.6 crores. While the revenue of the company decreased to Rs 1,073.6 crores against Rs 1,162.9 crores YoY.

However, Cyient Ltd on Friday reported a bearish trend in the stock market. The company lost 17.55 points with a 7.45% decrease and reached 214.4 INR. While in BSE, the company lost 17.65 points with a 7.62% decrease and reached 214.05 INR.

5paisa Capital Limited: The company on Thursday reported its Q4 results. The company reported a loss of Rs 1.7 crores as against Rs 0.73 crores. The companies revenue increased to Rs 35.40 crores as against Rs 20.90 crores YoY.

However, 5Paisa Capital Ltd on Friday reported a bearish trend in the stock market. The company lost 2.95 points with a 1.73% decrease and reached 168.00 INR. While in BSE, the company lost 4.15 points with a 2.40% decrease and reached 168.45 INR.

ICICI Securities Limited: The company on Thursday reported its Q4 results. The company’s profit increased to Rs 155.88 crores as against Rs 121.53 crores. The companies revenue increased to Rs 480.44 crores as against Rs 408.1 crores YoY.

However, ICICI Securities  Ltd on Friday reported a bullish trend in the stock market. The bank gained 15.00 points with a 4.00% increase and reached 393.05 INR. While in BSE, the bank gained 15.95 points with a 4.23% increase and reached 392.90 INR. 

SKF India Limited: The company on Thursday reported its Q4 results. The company’s profit decreased to Rs 75.34 crores as against Rs 82.2 crores. The companies revenue decreased to Rs 610.21 crores as against Rs 748.44 crores YoY.

However, SKF India  Ltd on Friday reported a bullish trend in the stock market. The company gained 93.60 points with a 6.96% increase and reached 1,438.00 INR. While in BSE, the company gained 92.90 points with a 6.90% increase and reached 1,439.00 INR. 

Hindustan Unilever Ltd: The company’s shares bought by Societe Generale by 1.29 crore equity shares at Rs 1,902 per share. On the other side, Horlicks and GSK sold 13.37 crore equity shares via block deals.

However, HUL  Ltd on Friday reported a bullish trend in the stock market. The company gained 52.70 points with a 2.65% increase and reached 2,044.35 INR. While in BSE, the company gained 52.55 points with a 2.64% increase and reached 2,045.05 INR. 

Apollo Pipes Ltd: The company’s shares bought by Sameer Gupta by almost 1,44,476 equity shares at Rs 323.73 per share.

However, Apollo Pipes Ltd on Friday reported a bullish trend in the stock market. The company gained 12.85 points with a 4.34% increase and reached 330.45 INR. While in BSE, the company gained 14.45 points with a 4.56% increase and reached 331.00 INR. 

Just Dial Ltd: The company shares sold by the Saudi Arabian Monetary Authority by almost 3,24,863 equity shares of Rs 339.85 per share.

However, Just Dial Ltd on Friday reported a bullish trend in the stock market. The company gained 12.55 points with a 3.74% increase and reached 347.90 INR. While in BSE, the company gained 10.55 points with a 3.15% increase and reached 347.25 INR. 

Top Gainers on May 7th: Dr. Reddys Labs, ICICI Bank, Reliance Industries, Sun Pharma, and Bharti Airtel are the top gainers in the stock market. 

Top Losers on May 7th: NTPC, Bharti Infratel, BPCL, M&M, and Power Grid are the top losers in the stock market.

The post Stocks in news May 8th: RIL, RBL Bank, HUL, Gillette, SKF, Just Dial appeared first on stockinvestor.in.

Source : Stockinvestor More   

What's Your Reaction?

like
0
dislike
0
love
0
funny
0
angry
0
sad
0
wow
0

Next Article

Malaria drug Trump touted as ‘game changer’ for coronavirus treatment fails in new study

Hydroxychloroquine failed to help those with infections stay off ventilators or live longer.

Malaria drug Trump touted as ‘game changer’ for coronavirus treatment fails in new study

A malaria drug that was touted by U.S. President Donald Trump and widely used as a potential treatment for patients with Covid-19 failed to help those with infections stay off ventilators or live longer, according to a study published in the New England Journal of Medicine.

Researchers at New York-Presbyterian Hospital and Columbia University Irving Medical Center in New York City evaluated 1,376 consecutive patients who showed up at the emergency room with symptoms of coronavirus, comparing the fate of those who received the medication, hydroxychloroquine, to those who didn’t. Nearly 60% of the patients were given the drug, typically within 48 hours, and they were more sick on average.

There were no significant differences between the groups in the number of patients who needed to be put on a ventilator or who died, even after taking into account the differences between them, the researchers said.

Additional study, including more scientifically rigorous trials that randomly assign patients to treatment groups, is needed to confirm the findings, they said.

The results shouldn’t be used to rule out either a potential benefit or harm from the drug, though they don’t support use of the medication outside of clinical trials, the researchers said. The medical center updated its clinical guidance to remove the suggestion that patients with Covid-19 should receive it.

When Trump began touting the drug as a “game changer” for Covid-19 in March, a frenzy ensued as hospitals, patients and doctors raced to secure supplies. The president has stopped talking about hydroxychloroquine as the tide has now turned against the drug, with regulators and scientists raising concerns about potentially serious side effects.

More coronavirus coverage from Fortune:

—The Rebuild Program: A project to —Real unemployment rate soars past 24.9%—and —McConnell focuses Senate on conservative judge appointments rather than coronavirus
—Photo essay: —Trump’s demand that China pay coronavirus reparations evokes —The coronavirus is driving a mental health crisis. Tech can help tackle it
—IBM thinks tech tested by astronauts could help us take care of isolated loved ones
—PODCAST: How Marc Benioff is helping out during the coronavirus pandemic
—WATCH: Fortune’s top 10 , Fortune’s weekly newsletter on what it takes to reboot business in the midst of a pandemic

Source : Fortune More   

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.